Multiple sclerosis progression: time for a new mechanism-driven framework.
Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, Marrie RA, Montalban X, Yong VW, Thompson AJ, Reich DS; International Advisory Committee on Clinical Trials in Multiple Sclerosis.
Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18.
Secondary Progressive Multiple Sclerosis: New Insights.
Cree BAC, Arnold DL, Chataway J, Chitnis T, Fox RJ, Pozo Ramajo A, Murphy N, Lassmann H.
Neurology. 2021 Aug 24;97(8):378-388. doi: 10.1212/WNL.0000000000012323. Epub 2021 Jun 4.
Diagnosis and treatment of progressive multiple sclerosis: A position paper.
Pozzilli C, Pugliatti M, Vermersch P, Grigoriadis N, Alkhawajah M, Airas L, Oreja-Guevara C.
Eur J Neurol. 2023 Jan;30(1):9-21. doi: 10.1111/ene.15593. Epub 2022 Oct 25.
Progressive multiple sclerosis: pathology and pathogenesis.
Lassmann H, van Horssen J, Mahad D.
Nat Rev Neurol. 2012 Nov 5;8(11):647-56. doi: 10.1038/nrneurol.2012.168. Epub 2012 Sep 25.
Progressive Multiple Sclerosis.
Amezcua L.
Continuum (Minneap Minn). 2022 Aug 1;28(4):1083-1103. doi: 10.1212/CON.0000000000001157.
Progressive Multiple Sclerosis.
Ontaneda D.
Continuum (Minneap Minn). 2019 Jun;25(3):736-752. doi: 10.1212/CON.0000000000000727.
Secondary progressive multiple sclerosis: a systematic review of costs and health state utilities.
Chataway J, Murphy N, Khurana V, Schofield H, Findlay J, Adlard N.
Curr Med Res Opin. 2021 Jun;37(6):995-1004. doi: 10.1080/03007995.2021.1904860. Epub 2021 Apr 6.
Current challenges in secondary progressive multiple sclerosis: diagnosis, activity detection and treatment.
Brieva L, Calles C, Landete L, Oreja-Guevara C.
Front Immunol. 2025 Mar 21;16:1543649. doi: 10.3389/fimmu.2025.1543649. eCollection 2025.
Diagnosing 'transition' to secondary progressive multiple sclerosis (SPMS): A step-by-step approach for clinicians.
Hamdy E, Talaat F, Ramadan I, Marouf H, Hamdy MM, Sadallah H, El-Ashmawy GAH, Elsalamawy D, Said SM.
Mult Scler Relat Disord. 2022 Apr;60:103718. doi: 10.1016/j.msard.2022.103718. Epub 2022 Mar 5.
Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA.
Carlson AK, Fox RJ.
Neurol Clin. 2024 Feb;42(1):39-54. doi: 10.1016/j.ncl.2023.07.002. Epub 2023 Aug 21.
